Clinical Trial Update: Safety and Performance Study of the Nyxoah SAT System for Treating OSA [NA]

View source ↗

Summary

Clinical trial update on the Nyxoah SAT System for obstructive sleep apnea reports safety and performance data; the study (NCT02312479) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Nyxoah SAT System

Snippet

Sponsor: Nyxoah S.A. | Conditions: Obstructive Sleep Apnea | NA | Status: TERMINATED